An Overview of Ulcerative Colitis for Healthcare Professionals

Supported by an educational grant from Celgene Corporation

TITLE - An Overview of Ulcerative Colitis for Healthcare Professionals

TARGET AUDIENCE - Target audiences for this program are Specialty Pharmacists, Pharmacists, Clinical Pharmacists, Specialty Pharmacy executives, Pharmacy Directors, Chief Pharmacy Officers, and Gastrointestinal Pharmacists

LEARNING OBJECTIVES - After completing the program, Specialty Pharmacists, Pharmacists, Clinical Pharmacists, Specialty Pharmacy executives, Pharmacy Directors, Chief Pharmacy Officers, and Gastrointestinal Pharmacists

  1. Recognize the increasing prevalence and epidemiology of ulcerative colitis (UC)
  2. Discuss the pathophysiology and potential risk factors for development of UC
  3. Describe the symptoms and clinical presentation of UC and differentiate UC from Crohn's Disease
  4. Recognize methods and tests used to diagnose UC
  5. Identify the classification and grading of UC
  6. List common extraintestinal manifestations of UC
  7. Recognize various pharmacologic and nonpharmacological treatments for patients with UC
  8. Describe strategies to prevent progression of UC

Faculty Disclosures:

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/ services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by the Specialty Pharma Education Center for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Pharmacist continuing education credit

Specialty Pharma Education Center (SPEC) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for 1.5 hours (0.15CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
ACPE #0535-0000-19-007-H01-P

Knowledge Based Activity

Course release date 2/25/2019

Course expires 2/25/2022

Credit Information

Activity Number Credit Amount Accreditation Period
0535-0000-19-007-H01-P 0.15 CEUs February 25, 2019 - February 25, 2022